Memory Supports for Cognitive Impairment
What You Need to Know Before You Apply
What is the purpose of this trial?
Alzheimer's disease and related dementias lead to marked declines in daily functioning, independence, and quality of life. One of the earliest cognitive changes in these conditions is impairment in prospective memory, or the ability to remember future intentions such as taking medications at a given time. Prior intervention studies that targeted prospective memory used mnemonic strategies or cognitive training, but these approaches resulted in modest gains in clinical populations. By contrast, a Stage I pilot trial indicated that smartphone-based memory aids (reminder apps) can be accepted and used by persons with mild cognitive impairment and mild dementia to improve both subjective and objective prospective memory performance. The investigators will now test for efficacy, durability, and generalizability of benefits across diverse samples in a Stage II randomized controlled trial. Some 200 participants with mild cognitive impairment or mild dementia will be recruited, half of whom will be from digitally-disadvantaged backgrounds (low socioeconomic status, rural, or historically underrepresented groups). Participants will complete baseline assessments and then be randomly assigned to a smartphone reminder app intervention or an active control condition that uses a paper- based memory support system. Across a 4-week intervention period, participants will complete patient-selected and experimenter-assigned prospective memory assessments and receive booster training sessions to promote self-efficacy with the intervention/control system. Durability of effects will be assessed at 3-month and 6-month follow-up sessions. As a secondary aim, study partners will be simultaneously enrolled to collect informant ratings, track how much study partners assist the participants, and determine whether improving prospective memory in patients improves quality of life in study partners (e.g., by reducing the double to-do list burden of remembering for themselves and for care recipients). As a third aim, the investigators will identify barriers and facilitators to smartphone interventions in digitally-disadvantaged individuals who have historically been underrepresented in technology and dementia research.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on memory aids rather than medication changes.
Is using digital or paper-based memory aids safe for people with cognitive impairments?
The studies suggest that using digital memory aids like Google Calendar and mobile phone reminders is generally safe for people with cognitive impairments, including those with Alzheimer's disease and brain injuries. These tools help improve memory and daily activity management without reported safety concerns.12345
How does the treatment 'Memory Supports for Cognitive Impairment' differ from other treatments for cognitive impairment?
This treatment is unique because it uses both digital tools like Google Calendar and paper-based systems to provide reminders and support for memory, which can be customized to fit individual needs and preferences, unlike traditional treatments that may not offer such flexibility or personalization.16789
What data supports the effectiveness of the treatment Digital - Google Calendar, Google Calendar, Digital Reminder App, Paper-Based Memory Support System, Paper-Based Memory Support System, Memory Aids, Reminder Systems for cognitive impairment?
Research shows that using Google Calendar as a memory aid can significantly reduce forgetting in people with severe memory problems. Additionally, the Memory Support System (MSS), which includes a calendar and organization system, has been shown to improve functional ability and independence in individuals with mild cognitive impairment.6791011
Who Is on the Research Team?
Michael Scullin, PhD
Principal Investigator
Baylor University
Are You a Good Fit for This Trial?
This trial is for individuals with Alzheimer's Disease, Cognitive Impairment, or Mild Dementia. It aims to include people from digitally-disadvantaged backgrounds as well. Participants should be able to complete memory assessments and willing to use either a smartphone app or paper-based system.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants complete baseline assessments before randomization
Intervention
Participants are randomly assigned to a smartphone reminder app intervention or a paper-based memory support system for a 4-week period
Follow-up
Durability of effects assessed at 3-month and 6-month follow-up sessions
What Are the Treatments Tested in This Trial?
Interventions
- Digital - Google Calendar
- Paper-Based Memory Support System
Find a Clinic Near You
Who Is Running the Clinical Trial?
Baylor University
Lead Sponsor
University of Texas at Austin
Collaborator
Baylor Scott and White Health
Collaborator
National Institute on Aging (NIA)
Collaborator